HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 584209Generated: October 31, 2026
Formaldehyde → (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl) 4-[4-(3,3-dimethylmorpholino)-2-butynyl]piperazine dihydrochloride
https://huagongshe.com/reaction/584209
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Formaldehyde | HCID 712 | — |
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 3,3-Dimethyl-4-(2-propynyl)morpholine hydrochloride | HCID 22342701 | — |
| Reactant | (2R)-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl)piperazine | HCID 54478438 | — |
| Catalyst | Copper sulfate pentahydrate | HCID 24463 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl) 4-[4-(3,3-dimethylmorpholino)-2-butynyl]piperazine dihydrochloride | HCID 86588519 | — |
Reaction Steps
A mixture of 3,3-dimethyl-4-(2-propynyl)morpholine hydrochloride (0.24 g), 37% aqueous formaldehyde (0.16 ml), (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3,4-dimethylbenzyl)piperazine (0.57 g), copper(II) sulfate pentahydrate (5 mg) and potassium iodide (20 mg) in 1,4-dioxane (0.7 ml) was stirred at 90° C. for 1 hour. After being cooled to room temperature, the mixture was poured into ice-water and the aqueous mixture was made alkaline with saturated aqueous sodium hydrogen carbonate solution. The resulting mixture was extracted with ethyl acetate. The extract was washed with brine, dried over magnesium sulfate and evaporated under reduced pressure. The residue was purified by column chromatography on silica gel using a mixed solvent of dichloromethane and methanol (40:1). The fractions containing the objective compound was collected and evaporated under reduced pressure and treated with 4N hydrogen chloride in ethyl acetate solution. The resulting mixture was evaporated under reduced pressure and the residue was recrystallized from a mixture of acetone and water to give colorless crystals of (2R)-1-[3,5-bis(trifluoromethyl) benzoyl]-2-(3,4-dimethylbenzyl)-4-[4-(3,3-dimethyl-morpholino)-2-butynyl]piperazine dihydrochloride (0.64 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06924278B2 |
|---|
| Source dataset | uspto-grants-2005_08 |
|---|
| ORD ID | ord-9369211a5b604872a279de101c3e74f7 |
|---|
| Source note | uspto-grants-2005_08 |
|---|